SANTA CRUZ, Calif. November 2016 – SomaGenics, an RNA-focused biotechnology company, announced expansion of its intellectual property portfolio with issue of two new patents for its RNA analysis technologies (miR-ID®...Read more
SANTA CRUZ, Calif. October 2016 – SomaGenics has been awarded a $1.8M two-year NIH SBIR Phase II grant to further develop its RealSeq®–AC technology for next-generation sequencing (NGS) of small...Read more
September, 2016 SomaGenics will present recent progress in its RNA detection and sshRNA therapeutics programs in two posters at the OTS Annual Meeting in Montreal, Quebec, September 25-28, 2016.
Santa Cruz, Calif. September 14, 2016 SomaGenics will present at the 7th non-coding RNA & RNAi Therapeutics conference by Global Technology Community on September 14 in Boston, MA. Dr. Johnston...Read more
Santa Cruz, Calif. July 28, 2016 SomaGenics Inc. today announced that it has signed a licensing agreement with Rubicon Genomics, Inc. for commercialization of SomaGenics’ RealSeq®-AC library preparation technology for sequencing...Read more